Delivery Order J50211C026-DJBBMAFB110012
- Not listed
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The order, valued at $1,727,489.49, is part of a larger indefinite delivery contract (IDC) between NIAID and UTMB to provide preclinical research services related to infectious diseases. The work will support NIAID's Pre-Clinical Models of Infectious Diseases program. This...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Texas Medical Branch at Galveston (UTMB). The contract, valued at $174,528.00, is a firm fixed-price delivery order with no set-aside designation. The contractor will extract historical raw data from all studies performed under previous indefinite delivery, indefinite quantity (IDIQ) contract mechanisms. This contract is part of a larger $146.3...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Texas Medical Branch at Galveston (UTMB), a U.S. state government medical institution and educational institution. The $417,060 delivery order was for task order funding under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, with a...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to the University of Texas Medical Branch at Galveston (UTMB). The $489,046.00 delivery order was placed under NIAID's larger $1,075,800.75 NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery contract (IDC). This IDC allows NIAID to efficiently order a range of preclinical research and...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The $3,465,763 cost-reimbursement task order is part of a larger indefinite delivery contract (IDC) valued at $146.3 million that UTMB holds with NIAID to provide preclinical services for infectious disease research. Under this task order, UTMB will conduct studies...
- This is a $1,179,674.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB). The contract is for pre-clinical models of infectious diseases research and is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract vehicle, which has a total ceiling value of $2,706,323.34. UTMB, a...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to the University of Texas Medical Branch at Galveston (UTMB). The $393,542.08 delivery order falls under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract supports UTMB's provision of pre-clinical research services, such as testing...
- This federal contract award is for a delivery order under the "NIAID Animal Models of Infectious Diseases 2010-2017" indefinite delivery contract held by the University of Texas Medical Branch at Galveston (UTMB). The $100,000 order supports unspecified work related to TAS::75 0885::TAS, which was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). As a state-controlled institution of higher learning,...
- This federal contract award is for a task order issued under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The prime contractor is the University of Texas Medical Branch (UTMB) at Galveston, a state government entity and educational institution with extensive experience supporting federal agencies in areas such as infectious disease research, clinical trials, and emergency preparedness. The...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,151,741.00 delivery order contract to the University of Texas Medical Branch at Galveston (UTMB) for preclinical research services related to infectious diseases. This contract is a task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract. UTMB, a state controlled institution of...
- J50211C026Indefinite Delivery Contract
- J50211C026-DJBBMAFB110012Delivery Order
This federal contract award was issued by a U.S. government agency to the University of Texas Medical Branch at Galveston (UTMB), a major academic health center that provides a wide range of medical education, research, and patient care services to the federal government. The $424,982.44 firm fixed-price delivery order does not have a set-aside designation. The contract is likely associated with a larger indefinite delivery contract (IDC) that UTMB holds with the National Institute of Allergy and Infectious Diseases (NIAID) to provide preclinical services for infectious disease research, including animal model development, medical countermeasure testing, and specialized reagent production. This $146.3 million single-award IDC allows NIAID to efficiently order a range of preclinical R&D services from UTMB to support the evaluation of candidate therapeutics, vaccines, and diagnostics against various pathogens. UTMB's extensive experience and specialized capabilities in areas like emerging infectious diseases, biodefense, and public health initiatives make it a valuable partner for federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 8/21/06 | |
| 12 | Funding Only Action | $425.0k | 8/21/06 |